HeartSciences (HSCS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
21 Oct, 2026Executive summary
Fortitude, a vertically integrated digital-asset mining platform anchored in Zcash, agreed to combine with the other party in an all-stock merger.
A DCG executive reposted a report that ZEC rose 12% to ~$1,270 as developers targeted Nov. 5 for the NU7 upgrade; the post said ZEC was up >148% YTD and the upgrade aimed to cut block times from 75 to 25 seconds.
Voting matters and shareholder proposals
Shareholder approval is a closing condition; a special meeting will consider the proposed merger, and proxy materials are to be mailed to eligible shareholders.
The definitive proxy statement was filed Oct. 19, 2026; shareholders were urged to review it and any amendments or supplements before deciding how to vote.
Risk oversight and compliance
Disclosed transaction risks include delay or failure to close, failure to obtain shareholder approval, adverse market conditions, integration challenges, and risks in managing a newly public entity.
Fortitude’s risks include cryptocurrency price volatility and significant legal, commercial, regulatory, and technical uncertainty around digital assets.
Fortitude monetizes all mined digital assets, including ZEC; Fortitude and affiliates, including DCG, may sell, pledge, or otherwise monetize holdings to fund expenses and investment, hedge exposure, or realize gains.
Forward-looking statements reflect current expectations and assumptions, are subject to known and unknown risks, and are not to be relied on unduly; the parties disclaim an update obligation except as required by law.
Latest events from HeartSciences
- All-stock merger faces shareholder, integration and digital-asset risks.HSCS
Proxy filing - Fortitude merger awaits shareholder approval amid crypto-market and execution risks.HSCS
Proxy filing - Proposed Up-C merger leaves existing shareholders with an estimated 6% stake.HSCS
Proxy filing - All-stock merger hinges on shareholder approval amid crypto and integration risks.HSCS
Proxy filing - FDA cleared MyoVista wavECG; commercialization awaits a cleared AI-ECG algorithm.HSCS
Proxy filing - All-stock merger proposal pairs Fortitude’s public-market plans with Zcash expansion.HSCS
Proxy filing - Fortitude Seller would control ~95% of votes, leaving legacy holders ~5%.HSCS
Proxy filing - FRV loan maturity extended to the earlier of the Fortitude closing trigger or Jan. 29, 2027.HSCS
Proxy filing - Shareholders to vote on all-stock merger combining digital asset mining and AI medical technology.HSCS
Proxy filing